ADMA

ADMA Biologics (ADMA)

About ADMA Biologics (ADMA)

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Details

Daily high
$13.50
Daily low
$10.90
Price at open
$13.40
52 Week High
$25.67
52 Week Low
$10.90
Market cap
3.2B
Dividend yield
0.00%
Volume
22.9M
Avg. volume
4.4M
P/E ratio
22.69

ADMA Biologics News

Details

Daily high
$13.50
Daily low
$10.90
Price at open
$13.40
52 Week High
$25.67
52 Week Low
$10.90
Market cap
3.2B
Dividend yield
0.00%
Volume
22.9M
Avg. volume
4.4M
P/E ratio
22.69